Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD Using High Throughput Single-cell RNA-Seq

NCT03438032 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03438032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03438032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD Using High Throughput Single-cell RNA-Seq
Lead sponsor
Northwestern University
Phase
Observational
Overall status
Completed
Start date
June 28, 2018
Completion date
March 8, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis lung, systemic sclerosis